fda glp-1 Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System Market Overview: GLP-1 Agonists and
Description
Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression
doi: 10.1073/pnas.0809158106
Those who qualify will pay $50 copays for the medicine
Funding Nil
